Minimal residual disease diagnostics in patients with multiple myeloma

被引:0
|
作者
Huhn, S. [1 ]
机构
[1] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V484
引用
收藏
页码:128 / 128
页数:1
相关论文
共 50 条
  • [41] MINIMAL RESIDUAL DISEASE AFTER BMT FOR MULTIPLE-MYELOMA
    BIRD, JM
    SAMSON, D
    RUSSELL, NH
    BLOOD, 1993, 82 (10) : A199 - A199
  • [42] Minimal Residual Disease in Multiple Myeloma Ready for Prime Time?
    Mina, Roberto
    Bonello, Francesca
    Oliva, Stefania
    CANCER JOURNAL, 2021, 27 (03): : 247 - 255
  • [43] Minimal Residual Disease in Multiple Myeloma Patients: Influence on Indicators of Progression Free Survival
    Garifullin, Andrei
    Voloshin, Sergei
    Martynkevich, Irina
    Kuvshinov, Alexey
    Kleina, Elizaveta
    Shuvaev, Vasily
    Abdulkadyrov, Kudrat
    BLOOD, 2016, 128 (22)
  • [44] The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients
    Campbell, Lauren
    Lau, I-Jun
    Ramasamy, Karthik
    Sadler, Ross
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S144 - S145
  • [45] Detection of tumor-specific marker for minimal residual disease in multiple myeloma patients
    Sedlarikova, Lenka
    Kubiczkova, Lena
    Kryukov, Fedor
    Pelcova, Jana
    Adam, Zdenek
    Pour, Ludek
    Hajek, Roman
    Sevcikova, Sabina
    BIOMEDICAL PAPERS-OLOMOUC, 2015, 159 (04): : 554 - 561
  • [46] DETECTION OF MINIMAL RESIDUAL DISEASE IN AUTOGRAFTS BY ASO-PCR FOR PATIENTS WITH MULTIPLE MYELOMA
    Ito, Shigeki
    Takamatsu, Hiroyuki
    Mine, Takahiro
    Oyake, Tatsuo
    Murai, Kazunori
    Ishida, Yoji
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients
    Kubiczkova-Besse, Lenka
    Drandi, Daniela
    Sedlarikova, Lenka
    Oliva, Stefania
    Gambella, Manuela
    Omede, Paola
    Adam, Zdenek
    Pour, Ludek
    Sevcikova, Sabina
    Boccadoro, Mario
    Palumbo, Antonio
    Hajek, Roman
    BLOOD, 2014, 124 (21)
  • [48] Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients with minimal residual disease
    Byun, J. M.
    Jung, E. H.
    Shin, D. -Y.
    Do, Y. R.
    Kim, H.
    Bae, S. H.
    Kim, S. -J.
    Kwak, J. -Y.
    Lee, S. M.
    Yoon, S. -S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 410 - 411
  • [49] Intestinal Microbiota Composition Is Associated with Minimal residual Disease Negativity in Patients with Multiple Myeloma
    Pianko, Matthew J.
    Devlin, Sean M.
    Littmann, Eric R.
    Chansakul, Aisara
    Mastey, Donna
    Salcedo, Meghan
    Fontana, Emily
    Ling, Lilan
    Tavitian, Elizabet
    Slingerland, John B.
    Slingerland, Ann E.
    Clurman, Annelie
    Gomes, Antonio L. C.
    Taur, Ying
    Pamer, Eric G.
    Peled, Jonathan U.
    van den Brink, Marcel R. M.
    Landgren, Ola
    Lesokhin, Alexander M.
    BLOOD, 2018, 132
  • [50] Measuring Minimal Residual Disease in Plasma of Multiple Myeloma Patients By Intact Mass Spectrometry
    Genovesi, Luca
    Schirm, Michael
    Dupuis, Nick
    Pottiez, Gwenael
    BLOOD, 2023, 142